The global hemodialysis and peritoneal dialysis market is expanding rapidly as the prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetes, hypertension, and obesity continues to increase. The global hemodialysis and peritoneal dialysis market size was valued at USD 119.5 billion in 2025 and is projected to grow from USD 129.8 billion in 2026 to USD 250.4 billion by 2033, registering a CAGR of 9.8% from 2026 to 2033. North America held the largest share of 38.1% of the global market in 2025.

Growing demand for long-term renal replacement therapies is supporting market expansion across hospitals, dialysis centers, and home-care settings. Rising cases of CKD are particularly important because the condition can progress to ESRD, where dialysis becomes essential. Increasing awareness, improved screening programs, technological advancements, and greater investment in dialysis infrastructure are also creating opportunities for manufacturers and healthcare providers.

Download a free sample copy of the Hemodialysis And Peritoneal Dialysis market report to understand detailed coverage and inclusions in the final report

Market Breakdown by Modality

Hemodialysis remains the leading modality in the market. The hemodialysis segment accounted for an 82.9% revenue share in 2025 and is expected to grow at the fastest CAGR over the forecast period. The segment includes conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis includes Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD).

Peritoneal dialysis is gaining attention because of its suitability for home-based treatment and its flexibility compared with facility-based care. The increasing ESRD patient population, aging demographics, and rising incidence of diabetes and hypertension are contributing to demand for both modalities.

Core Product & Service Segments

Services represented the largest product segment, accounting for 56.7% of revenue in 2025. The segment benefits from the growing number of patients requiring continuous dialysis care and the expansion of dialysis service providers. Consumables are projected to grow at the fastest CAGR, supported by demand for catheters, bloodlines, concentrates, and other recurring treatment products. Device offerings include machines, dialyzers, water treatment systems, and other equipment.

By end use, the hospital-based segment accounted for the largest revenue share of 76.3% in 2025. However, the home-based segment is projected to register the fastest CAGR, supported by greater flexibility, lower travel requirements, improved mobility, and advances in smaller and easier-to-use dialysis systems.

Key Market Trends & Drivers

The Shift to Home Care

Home-based dialysis is becoming an important growth opportunity as patients and healthcare providers seek more flexible treatment models. Advances in portable and automated systems are helping reduce dependence on conventional dialysis centers. Smaller machines, simpler connections, and remote monitoring technologies are supporting greater patient independence and convenience.

Technological Integration

Technology is transforming dialysis through advanced machines, high-flux dialyzers, automated peritoneal dialysis systems, digital health platforms, real-time monitoring, and artificial intelligence-enabled solutions. These developments are designed to improve treatment efficiency, patient management, safety, and convenience while supporting the expansion of home-based care.

Regional Dynamics

North America dominated the market with a 38.1% revenue share in 2025, supported by established healthcare infrastructure, government funding, reimbursement conditions, and significant industry participation. Asia Pacific is anticipated to register the fastest CAGR during the forecast period, driven by increasing renal disease rates, aging populations, government initiatives, CKD awareness programs, and investments in modern healthcare facilities.

Major Global Competitors

The market is characterized by established companies with extensive dialysis infrastructure, product portfolios, distribution networks, and research capabilities. Key companies profiled by Grand View Research include Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., DaVita (Optum), BD, Nikkiso Co., Ltd., Diaverum (M42), and vivISOL.

Market Leaders

Established players are investing in advanced hemodialysis and peritoneal dialysis technologies, expanding clinic networks, strengthening distribution channels, and enhancing integrated care services. Their extensive infrastructure, regulatory expertise, and established brands provide significant competitive advantages.

Key Hemodialysis And Peritoneal Dialysis Companies:

Baxter
B. Braun SE
Fresenius Medical Care AG
Medtronic

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Hemodialysis Remains Dominant as Home Renal Care Gains

The global hemodialysis and peritoneal dialysis market size was valued at USD 119.5 billion in 2025 and is projected to grow from USD 129.8 billion in 2026